tumor

Scientists discovered that healthy epithelial cells recognize their precancerous neighbors via the expression of proteins normally only found on immune cells. The proteins that mediate this recognition between healthy and precancerous cells provide a potential new therapeutic avenue for treating cancer.

In children, T cells effectively combat acute infections such as COVID-19, but a new study in mice suggests that the T cell response is detrimental when fighting pediatric tumors.

Sperm, bacteria, bubbles, and shuttles are just some of the latest cancer-treating microrobots in development for human use in the next few years.

Immunotherapy was a game-changer for the cancer field, but immunotherapies using cytokines like IL-2 often cause severe side effects. Researchers are developing a newly engineered blueprint to improve the therapeutic efficacy and safety of IL-2 and other cytokines.

Grant from Innovate UK to Pathios seeks to advance cancer immunotherapy

Oncologists seek clarity via patient-derived models

Study teams up protein biomarkers to increase accuracy of early breast cancer detection